Form 4: Director Glenn Eisenberg Receives RSU Grant at Lumexa

Sentiment:

Statement of Changes in Beneficial Ownership


Director Glenn Eisenberg was granted 19,358 restricted stock units in Lumexa Imaging Holdings, Inc. on June 10, 2026.

Summary

  • Director Glenn A. Eisenberg acquired 19,358 restricted stock units (RSUs) of Lumexa Imaging Holdings, Inc. common stock.
  • Each RSU represents a contingent right to receive one share of common stock.
  • The grant was issued on June 10, 2026, at a price of $0 per share.
  • The RSUs are subject to a vesting schedule tied to the earlier of the one-year anniversary of the grant or the next annual stockholders' meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

  • Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

  • Potential for future dilution of existing shareholders upon the vesting and issuance of the underlying common stock.

Risks

  • Vesting is contingent upon the director's continued service with the company.

Future Outlook

The RSUs will vest on the earlier of the one-year anniversary of the grant date (June 10, 2027) or the next annual meeting of the Issuer's stockholders, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize board members and align their interests with those of the shareholders.

Comparison to Industry Standards

  • The use of RSUs as a component of director compensation is consistent with standard practices for publicly traded companies in the healthcare and technology sectors.
  • The one-year vesting period is a common benchmark for director equity awards.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of AttorneyGlenn A. Eisenberg appointed Paul Gilbert and Ricardo Alvarado as attorneys-in-fact for SEC filings.03/03/2026Standard administrative procedure to ensure timely compliance with SEC reporting requirements.

Stakeholder Impact

  • Shareholders: Minor dilution impact upon future vesting of shares.

Next Steps

  • Vesting of the 19,358 RSUs on the earlier of June 10, 2027, or the next annual stockholders' meeting.

Key Dates

DateDescription
03/03/2026Date of execution for the Power of Attorney.
06/10/2026Date of the RSU grant transaction.
06/12/2026Date of filing the Form 4 with the SEC.

Keywords

Lumexa Imaging Holdings, LMRI, Form 4, Insider Trading, Restricted Stock Units, Director Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.